308 related articles for article (PubMed ID: 17354167)
41. Anti-aromatase activity of phytochemicals in white button mushrooms (Agaricus bisporus).
Chen S; Oh SR; Phung S; Hur G; Ye JJ; Kwok SL; Shrode GE; Belury M; Adams LS; Williams D
Cancer Res; 2006 Dec; 66(24):12026-34. PubMed ID: 17178902
[TBL] [Abstract][Full Text] [Related]
42. Grape seed extract is an aromatase inhibitor and a suppressor of aromatase expression.
Kijima I; Phung S; Hur G; Kwok SL; Chen S
Cancer Res; 2006 Jun; 66(11):5960-7. PubMed ID: 16740737
[TBL] [Abstract][Full Text] [Related]
43. The non-estrogenic alternative for the treatment of climacteric complaints: Black cohosh (Cimicifuga or Actaea racemosa).
Wuttke W; Jarry H; Haunschild J; Stecher G; Schuh M; Seidlova-Wuttke D
J Steroid Biochem Mol Biol; 2014 Jan; 139():302-10. PubMed ID: 23459142
[TBL] [Abstract][Full Text] [Related]
44. Formestane in the treatment of advanced postmenopausal breast cancer.
Possinger K; Jonat W; Höffken K
Ann Oncol; 1994; 5 Suppl 7():S7-10. PubMed ID: 7873464
[TBL] [Abstract][Full Text] [Related]
45. Gene expression profiling reveals effects of Cimicifuga racemosa (L.) NUTT. (black cohosh) on the estrogen receptor positive human breast cancer cell line MCF-7.
Gaube F; Wolfl S; Pusch L; Kroll TC; Hamburger M
BMC Pharmacol; 2007 Sep; 7():11. PubMed ID: 17880733
[TBL] [Abstract][Full Text] [Related]
46. Molecular mechanisms of aromatase inhibition by new A, D-ring modified steroids.
Cepa M; Correia-da-Silva G; Tavares da Silva EJ; Roleira FM; Hong Y; Chen S; Teixeira NA
Biol Chem; 2008 Sep; 389(9):1183-91. PubMed ID: 18713005
[TBL] [Abstract][Full Text] [Related]
47. First-time proof of endometrial safety of the special black cohosh extract (Actaea or Cimicifuga racemosa extract) CR BNO 1055.
Raus K; Brucker C; Gorkow C; Wuttke W
Menopause; 2006; 13(4):678-91. PubMed ID: 16837890
[TBL] [Abstract][Full Text] [Related]
48. A dietary supplement for female sexual dysfunction, Avlimil, stimulates the growth of estrogen-dependent breast tumors (MCF-7) implanted in ovariectomized athymic nude mice.
Ju YH; Doerge DR; Helferich WG
Food Chem Toxicol; 2008 Jan; 46(1):310-20. PubMed ID: 17919800
[TBL] [Abstract][Full Text] [Related]
49. Efficacy and safety of isopropanolic black cohosh extract for climacteric symptoms.
Reed S; Newton K; LaCroix A; Grothaus L
Obstet Gynecol; 2005 Nov; 106(5 Pt 1):1111; author reply 1111-2. PubMed ID: 16260542
[No Abstract] [Full Text] [Related]
50. Superiority of gas chromatography/tandem mass spectrometry assay (GC/MS/MS) for estradiol for monitoring of aromatase inhibitor therapy.
Santen RJ; Demers L; Ohorodnik S; Settlage J; Langecker P; Blanchett D; Goss PE; Wang S
Steroids; 2007 Jul; 72(8):666-71. PubMed ID: 17588628
[TBL] [Abstract][Full Text] [Related]
51. Estrogens participate in the antidepressant-like effect of desipramine and fluoxetine in male rats.
Martínez-Mota L; Cruz-Martínez JJ; Márquez-Baltazar S; Fernández-Guasti A
Pharmacol Biochem Behav; 2008 Jan; 88(3):332-40. PubMed ID: 17915301
[TBL] [Abstract][Full Text] [Related]
52. Pharmacological profiles of exemestane and formestane, steroidal aromatase inhibitors used for treatment of postmenopausal breast cancer.
Lønning PE
Breast Cancer Res Treat; 1998; 49 Suppl 1():S45-52; discussion S73-7. PubMed ID: 9797017
[TBL] [Abstract][Full Text] [Related]
53. Aromatase inhibitor and bone.
Miki Y; Suzuki T; Sasano H
Biomed Pharmacother; 2007 Oct; 61(9):540-2. PubMed ID: 17904790
[TBL] [Abstract][Full Text] [Related]
54. A multicentre, randomized, pharmacokinetic, endocrine and clinical study to evaluate formestane in breast cancer patients at first relapse: endocrine and clinical results. The Italian Trials in Medical Oncology (I.T.M.O.) group.
Bajetta E; Zilembo N; Barni S; Noberasco C; Martinetti A; Ferrari L; Schieppati G; Buzzoni R; Jirillo A; Amichetti M; D'Aprile M; Comella G; Bichisao E; Bolelli GF; Attili A; Bombardieri E
Ann Oncol; 1997 Jul; 8(7):649-54. PubMed ID: 9296217
[TBL] [Abstract][Full Text] [Related]
55. Activation of rapid signaling pathways and the subsequent transcriptional regulation for the proliferation of breast cancer MCF-7 cells by the treatment with an extract of Glycyrrhiza glabra root.
Dong S; Inoue A; Zhu Y; Tanji M; Kiyama R
Food Chem Toxicol; 2007 Dec; 45(12):2470-8. PubMed ID: 17664038
[TBL] [Abstract][Full Text] [Related]
56. Inhibition of the phosphatidylinositol 3-kinase/Akt pathway improves response of long-term estrogen-deprived breast cancer xenografts to antiestrogens.
Sabnis G; Goloubeva O; Jelovac D; Schayowitz A; Brodie A
Clin Cancer Res; 2007 May; 13(9):2751-7. PubMed ID: 17473209
[TBL] [Abstract][Full Text] [Related]
57. The growth-promoting action of individual women's sera on mammary carcinoma cells.
Auer D; Hubalek M; Fleischer M; Roessler J; Daxenbichler G
Anticancer Res; 2008; 28(4B):2213-7. PubMed ID: 18751397
[TBL] [Abstract][Full Text] [Related]
58. Treatment of advanced breast cancer with formestane.
Murray R; Pitt P
Ann Oncol; 1994; 5 Suppl 7():S11-3. PubMed ID: 7873455
[TBL] [Abstract][Full Text] [Related]
59. Protective effect of Operculina turpethum against 7,12-dimethyl benz(a)anthracene induced oxidative stress with reference to breast cancer in experimental rats.
Anbuselvam C; Vijayavel K; Balasubramanian MP
Chem Biol Interact; 2007 Jul; 168(3):229-36. PubMed ID: 17531963
[TBL] [Abstract][Full Text] [Related]
60. Tamoxifen and aromatase inhibitors differentially affect vascular endothelial growth factor and endostatin levels in women with breast cancer.
Holmes CE; Huang JC; Pace TR; Howard AB; Muss HB
Clin Cancer Res; 2008 May; 14(10):3070-6. PubMed ID: 18483373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
